All Curated Mutation Sites in HSV2 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HSV2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
TK
  
DNA pol
  
UL52
  
UL5
  
UL30
  
UL23
  

Keyword: Cell line-29186456
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 29186456 M789T
DNA pol
UL30
Cell line
D
R
View
2 29186456 A724V
DNA pol
UL30
Cell line
D
R
View
3 29186456 N820S
DNA pol
UL30
Cell line
R
View
4 29186456 K533E
DNA pol
UL30
Cell line
D
R
View
5 29186456 A606V
DNA pol
UL30
Cell line
D
R
View
6 29186456 C625R
DNA pol
UL30
Cell line
D
R
View
7 29186456 R628C
DNA pol
UL30
Cell line
D
R
View
8 29186456 S725G
DNA pol
UL30
Cell line
D
R
View
9 29186456 S729N
DNA pol
UL30
Cell line
D
R
View
10 29186456 I731F
DNA pol
UL30
Cell line
D
R
View
11 29186456 Q732R
DNA pol
UL30
Cell line
D
R
View
12 29186456 M789K
DNA pol
UL30
Cell line
D
R
View
13 29186456 V818A
DNA pol
UL30
Cell line
D
R
View
14 29186456 Y823C
DNA pol
UL30
Cell line
D
R
View
15 29186456 R847C
DNA pol
UL30
Cell line
D
R
View
16 29186456 F923L
DNA pol
UL30
Cell line
D
R
View
17 29186456 T934A
DNA pol
UL30
Cell line
D
R
View
18 29186456 R964H
DNA pol
UL30
Cell line
D
R
View
Contents
Description

The table shows all curated mutation sites of HSV2 in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.